WEDBUSH SECURITIES INC - REXAHN PHARMACEUTICALS INC ownership

REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640200. A total of 29 filers reported holding REXAHN PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WEDBUSH SECURITIES INC ownership history of REXAHN PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$13,000
-45.8%
25,5000.0%0.00%
-66.7%
Q4 2018$24,000
-46.7%
25,5000.0%0.00%
-40.0%
Q3 2018$45,000
+25.0%
25,5000.0%0.01%
+25.0%
Q2 2018$36,000
-7.7%
25,5000.0%0.00%
-20.0%
Q1 2018$39,000
-25.0%
25,5000.0%0.01%
-16.7%
Q4 2017$52,000
-16.1%
25,5000.0%0.01%
-25.0%
Q3 2017$62,000
+106.7%
25,500
+142.9%
0.01%
+100.0%
Q2 2017$30,00010,5000.00%
Other shareholders
REXAHN PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
CVI Holdings, LLC 1,547,837$1,439,0003.20%
Anson Funds Management LP 607,113$565,0000.33%
Benin Management CORP 14,300$13,0000.01%
NORTHWEST WEALTH MANAGEMENT, LLC 4,000$4,0000.00%
WEDBUSH SECURITIES INC 25,500$24,0000.00%
Virtu Financial LLC 45,555$42,0000.00%
Northeast Financial Consultants Inc 15,000$14,0000.00%
Capital Advisory Group Advisory Services, LLC 900$1,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 103,100$96,0000.00%
FRONTIER INVESTMENT MGMT CO 20,000$19,0000.00%
View complete list of REXAHN PHARMACEUTICALS INC shareholders